Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of BRCA mutations on chemotherapy-induced loss of ovarian reserve: A prospective longitudinal study
    Meeting Abstract

    Oktay, K.; Bedoschi, G.; Goldfarb, S. B.; Taylan, E.; Titus, S.; Palomaki, G. E.; Cigler, T.; Robson, M.; Dickler, M. N.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Metaplastic breast carcinomas and uterine carcinosarcomas are histologically and genetically related
    Meeting Abstract

    Da Cruz Paula, A.; Brown, D.; Geyer, F. C.; Smith, E.; Pareja, F.; Papanastasiou, A. D.; Fusco, N.; Marchio, C.; Brogi, E.; Wen, H. Y.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with high risk breast cancer (BC): Role of collagen processing and tumor microenvironment
    Meeting Abstract

    Liu, Y. L.; Bager, C. L.; Willumsen, N.; Kornhauser, N.; Cobham, M.; Andreopoulou, E.; Cigler, T.; Moore, A.; LaPolla, D.; Fitzpatrick, V.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Solomon, S.; Rodine, M.; DiLauro Abaya, C.; Leal, J. H. S.; Patil, S.; Norton, L.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study
    Meeting Abstract

    Modi, S.; Tsurutani, J.; Tamura, K.; Park, H.; Sagara, Y.; Murthy, R.; Iwata, H.; Krop, I. E.; Doi, T.; Redfern, C.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 for estrogen receptor-positive (ER plus ) advanced breast cancer (ABC) with progression on endocrine therapy (ET)
    Meeting Abstract

    Jhaveri, K.; Curigliano, G.; Yap, Y. S.; Cresta, S.; Duhoux, F. P.; Terret, C.; Takahashi, S.; Ulaner, G. A.; Kundamal, N.; Baldoni, D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
    Meeting Abstract

    Kumar, R.; Pei, X.; Selenica, P.; Wen, H. Y.; Powell, S.; Robson, M.; Riaz, N.; Reis-Filho, J. S.; Weigelt, B.; Mandelker, D.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The CHANCE study: Mechanical skin changes among women with non-metastatic breast cancer receiving chemotherapy and endocrine therapy
    Meeting Abstract

    Lacouture, M. E.; Phillips, G. S.; Freites-Martinez, A.; Patil, S.; Samuels, A.; Shapiro, J.; Kukoyi, O.; Goldfarb, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Whole exome sequencing analysis of the progression from ductal carcinoma in situ to invasive ductal carcinoma
    Meeting Abstract

    Lee, J. Y.; Bi, R.; Pareja, F.; Geyer, F. C.; Brown, D.; Wen, H. Y.; Norton, L.; Hicks, J.; Weigelt, B.; Reis-Filho, J. S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save